Anaesthesia in abalone, Haliotis midae
- Authors: White, Hermien Ilse
- Date: 1996
- Subjects: Abalones , Animal anesthesia
- Language: English
- Type: Thesis , Masters , MSc
- Identifier: vital:5216 , http://hdl.handle.net/10962/d1005059 , Abalones , Animal anesthesia
- Description: The principle aim of this study was to isolate a chemical for the "safe anaesthesia" of abalone under commercial farming conditions. "Safe anaesthesia" implied that the anaesthetic had no immediate detrimental or long term sublethal effect on the abalone, that it was safe for the farmer, the consumer and the environment. Four chemicals, magnesium sulphate (MgS0₄), ethylenediamine tetra-acetic acid (EDTA), 2-phenoxyethanol and procaine hydrochloride were shown to effectively inhibit the in vitro contraction of isolated tarsal muscle of Haliotis midae. This identified them as potential anaesthetics for abalone. Since abalone, like any other aquaculture species, would be subject to frequent size-sorting during the grow-out period, size related dosage tables were developed for the four chemicals at a temperature of 18⁰C. Dosage tables were also developed for benzocaine and carbon dioxide (C0₂), Three size classes (5-15, 20-50 and 60-90 mm shell length (SL)) of abalone were considered. Only three of the six chemicals, viz. MgS0₄, 2-phenoxyethanol and CO₂, met the criteria of an effective abalone anaesthetic in that they effected rapid and mortality-free anaesthesia. The other three chemicals caused mortalities and were considered to be unsuitable for commercial scale anaesthesia. Temperature related dosage tables were then developed for MgS0₄ and CO₂, MgS0₄ concentrations and CO₂ flow rates for effective anaesthesia in abalone were found to be inversely related to temperature. The three size classes of H. midae were intermittently exposed to MgS0₄ and 2-phenoxyethanol anaesthesia for an eight month period to determine the effect of the anaesthetics on growth rate. Because of an increased resistance to the efficacy of 2-phenoxyethanol and high monthly mortalities it was concluded that this chemical was unsafe and unsuitable for commercial use. MgS0₄, on the other hand, had no effect on growth of abalone and no significant effect on the rate of mortality. MgS0₄ also had no measurable effect on H. midae muscle ultrastructure and, by implication had no effect on flesh texture. The use of MgS0₄ as an anaesthetic would, therefore, not affect marketability. Moreover, no magnesium residues were found in H. midae muscle tissue after short term or intermittent long term exposure to MgS0₄ anaesthesia. It was found that the three size classes of H. midae used in this study could be safely exposed to the recommended MgS0₄ concentrations for up to 40 minutes without any mortalities. This is more than adequate for routine farming procedures. Medium size abalone (20-50 mm SL) were also safely exposed to 14 g.100 ml⁻¹ MgS0₄ for up to 6 hours without any mortalities. The results have shown that MgS0₄ was undoubtedly the best chemical that was evaluated for anaesthesia of H. midae in this study. It fulfils the requirements set forth by the U.S.A. Food and Drug Administration (FDA) in that it is safe for the abalone, the farmer, the consumer and the environment.
- Full Text:
- Authors: White, Hermien Ilse
- Date: 1996
- Subjects: Abalones , Animal anesthesia
- Language: English
- Type: Thesis , Masters , MSc
- Identifier: vital:5216 , http://hdl.handle.net/10962/d1005059 , Abalones , Animal anesthesia
- Description: The principle aim of this study was to isolate a chemical for the "safe anaesthesia" of abalone under commercial farming conditions. "Safe anaesthesia" implied that the anaesthetic had no immediate detrimental or long term sublethal effect on the abalone, that it was safe for the farmer, the consumer and the environment. Four chemicals, magnesium sulphate (MgS0₄), ethylenediamine tetra-acetic acid (EDTA), 2-phenoxyethanol and procaine hydrochloride were shown to effectively inhibit the in vitro contraction of isolated tarsal muscle of Haliotis midae. This identified them as potential anaesthetics for abalone. Since abalone, like any other aquaculture species, would be subject to frequent size-sorting during the grow-out period, size related dosage tables were developed for the four chemicals at a temperature of 18⁰C. Dosage tables were also developed for benzocaine and carbon dioxide (C0₂), Three size classes (5-15, 20-50 and 60-90 mm shell length (SL)) of abalone were considered. Only three of the six chemicals, viz. MgS0₄, 2-phenoxyethanol and CO₂, met the criteria of an effective abalone anaesthetic in that they effected rapid and mortality-free anaesthesia. The other three chemicals caused mortalities and were considered to be unsuitable for commercial scale anaesthesia. Temperature related dosage tables were then developed for MgS0₄ and CO₂, MgS0₄ concentrations and CO₂ flow rates for effective anaesthesia in abalone were found to be inversely related to temperature. The three size classes of H. midae were intermittently exposed to MgS0₄ and 2-phenoxyethanol anaesthesia for an eight month period to determine the effect of the anaesthetics on growth rate. Because of an increased resistance to the efficacy of 2-phenoxyethanol and high monthly mortalities it was concluded that this chemical was unsafe and unsuitable for commercial use. MgS0₄, on the other hand, had no effect on growth of abalone and no significant effect on the rate of mortality. MgS0₄ also had no measurable effect on H. midae muscle ultrastructure and, by implication had no effect on flesh texture. The use of MgS0₄ as an anaesthetic would, therefore, not affect marketability. Moreover, no magnesium residues were found in H. midae muscle tissue after short term or intermittent long term exposure to MgS0₄ anaesthesia. It was found that the three size classes of H. midae used in this study could be safely exposed to the recommended MgS0₄ concentrations for up to 40 minutes without any mortalities. This is more than adequate for routine farming procedures. Medium size abalone (20-50 mm SL) were also safely exposed to 14 g.100 ml⁻¹ MgS0₄ for up to 6 hours without any mortalities. The results have shown that MgS0₄ was undoubtedly the best chemical that was evaluated for anaesthesia of H. midae in this study. It fulfils the requirements set forth by the U.S.A. Food and Drug Administration (FDA) in that it is safe for the abalone, the farmer, the consumer and the environment.
- Full Text:
A study of the effect of progesterone on the body weight regulation in intact female rats
- Authors: Ravelingien, Jo
- Date: 1992
- Subjects: Progesterone -- Physiological effect , Body weight -- Regulation , Rats -- Research
- Language: English
- Type: Thesis , Masters , MSc
- Identifier: vital:3787 , http://hdl.handle.net/10962/d1003265 , Progesterone -- Physiological effect , Body weight -- Regulation , Rats -- Research
- Description: It is the aim of this study to elucidate the influence of progesterone on body weight regulation in intact female rats. A study of the literature includes a description of the body weight regulation and the effects of ovarian hormones on it. The controlled-system approach tries to link behavioral and physiological factors altering energy balance. The experimental study is subdivided into food-intake - and food-selection studies, a locomotor activity study, a study eliciting a possible role of thermogenesis, and finally rat liver studies which consist of a gas chromatography analysis of hepatic fatty acids and an electron microscopy study examining the ultrastructure of hepatocytes. It can be concluded that the effect of progesterone treatment on the body weight of intact female rats depends on the route of administration. There is a significant increase in body weight after subcutaneous progesterone injections without changes in total caloric intake and nutrient selection habits, indicating the importance of energy expenditure. But changes in spontaneous activity make no contribution in the progesterone-induced energy storage. It is also concluded that peripherally located brown adipose tissue thermogenesis is not changed, without ruling out the effect of more centrally located thermogenic organs as the liver. In this organ, small but significant changes in the fatty acid profile occur during the subcutaneous progesterone treatment.
- Full Text:
- Authors: Ravelingien, Jo
- Date: 1992
- Subjects: Progesterone -- Physiological effect , Body weight -- Regulation , Rats -- Research
- Language: English
- Type: Thesis , Masters , MSc
- Identifier: vital:3787 , http://hdl.handle.net/10962/d1003265 , Progesterone -- Physiological effect , Body weight -- Regulation , Rats -- Research
- Description: It is the aim of this study to elucidate the influence of progesterone on body weight regulation in intact female rats. A study of the literature includes a description of the body weight regulation and the effects of ovarian hormones on it. The controlled-system approach tries to link behavioral and physiological factors altering energy balance. The experimental study is subdivided into food-intake - and food-selection studies, a locomotor activity study, a study eliciting a possible role of thermogenesis, and finally rat liver studies which consist of a gas chromatography analysis of hepatic fatty acids and an electron microscopy study examining the ultrastructure of hepatocytes. It can be concluded that the effect of progesterone treatment on the body weight of intact female rats depends on the route of administration. There is a significant increase in body weight after subcutaneous progesterone injections without changes in total caloric intake and nutrient selection habits, indicating the importance of energy expenditure. But changes in spontaneous activity make no contribution in the progesterone-induced energy storage. It is also concluded that peripherally located brown adipose tissue thermogenesis is not changed, without ruling out the effect of more centrally located thermogenic organs as the liver. In this organ, small but significant changes in the fatty acid profile occur during the subcutaneous progesterone treatment.
- Full Text:
- «
- ‹
- 1
- ›
- »